Data catalog

MHRA paediatric investigation plans

About 1,120 records

More records

Continuing the MHRA paediatric investigation plans list, 1000 records per page, after mhra-101319-pip01-23-m01-update.

  1. mhra-101323-pip01-23tulisokibart
  2. mhra-101323-pip02-24tulisokibart
  3. REGADENOSON
  4. REGADENOSON
  5. mhra-101326-pip01-24Human IgG4 monoclonal antibody against BCMA and CD3
  6. mhra-101333-pip01-242-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl…
  7. mhra-101334-pip01-24Insulin Efsitora Alfa (LY3209590)
  8. LANDIOLOL HYDROCHLORIDE
  9. DENGUE VIRUS SEROTYPE 2 EXPRESSING DENGUE VIRUS SEROTYPE 1 SURFACE PROTEINS LIVE…
  10. DENGUE VIRUS SEROTYPE 2 EXPRESSING DENGUE VIRUS SEROTYPE 1 SURFACE PROTEINS LIVE…
  11. mhra-101338-pip01-24elinzanetant
  12. ESKETAMINE HYDROCHLORIDE
  13. mhra-101349-pip01-24SECUKINUMAB
  14. mhra-101350-pip01-24DECITABINE
  15. Autologous tumour-infiltrating lymphocytes (LN-144/LN-145)
  16. mhra-101354-pip01-24UPADACITINIB
  17. mhra-101355-pip01-24(3S,10S,14S)-1-[4-[[(2S)-4-carboxy-2-[(2S)-4-carboxy-2-(6-[18F]…
  18. mhra-101356-pip01-24inebilizumab
  19. mhra-101359-pip01-24spesolimab
  20. Purified Rabies virus, WISTAR PM/WI 38-1503-3M strain (inactivated)
  21. ZANAMIVIR
  22. FREMANEZUMAB
  23. mhra-101378-pip01-24UPADACITINIB
  24. mhra-101379-pip01-24Broadly neutralizing anti-HIV human monoclonal antibody (VH3810109)
  25. mhra-101384-pip01-24Telisotuzumab adizutecan
  26. mhra-101385-pip01-24Valemetostat tosilate
  27. DARIDOREXANT HYDROCHLORIDE
  28. DARIDOREXANT HYDROCHLORIDE
  29. mhra-101389-pip01-24omaveloxolone
  30. mhra-101392-pip01-24Influenza Virus Type A, H1N1
  31. mhra-101394-pip01-24clascoterone
  32. mhra-101395-pip01-24Zanidatamab
  33. mhra-101400-pip01-24nirogacestat hydrobromide
  34. mhra-101404-pip01-24TRASTUZUMAB DERUXTECAN
  35. mhra-101407-pip01-24chikungunya virus virus-like particle
  36. IVOSIDENIB
  37. mhra-101410-pip01-24ISATUXIMAB
  38. mhra-101411-pip01-24Erdafitinib
  39. mhra-101422-pip01-24Single-stranded 5' capped mRNA encoding the HAs of the influenza virus strains A/H1N1…
  40. mhra-101422-pip02-24single-stranded 5' capped mRNA encoding the HAs of the influenza virus strains A and B and…
  41. mhra-101426-pip01-24Deutetrabenazine
  42. mhra-101431-pip01-24SODIUM PHENYLBUTYRATE
  43. mhra-101435-pip01-24Hemopexin, human
  44. (R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-imidazo[4,5-c]pyridin-2(3H…
  45. mhra-101441-pip01-24modified recombinant version of the human myeloid-derived growth factor
  46. mhra-101442-pip01-24Modified messenger ribonucleic acid encoding individual patient-specific tumour…
  47. mhra-101445-pip01-24CANNABIDIOL
  48. DIFELIKEFALIN ACETATE
  49. mhra-101451-pip01-24Osivelotor
  50. Osivelotor
  51. mhra-101454-pip01-24Donidalorsen
  52. mhra-101457-pip01-24Acasunlimab
  53. mhra-101465-pip01-24anitocabtagene autoleucel
  54. mhra-101467-pip01-24apitegromab
  55. mhra-101468-pip01-24DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
  56. mhra-101469-pip01-24Garetosmab
  57. BELATACEPT
  58. mhra-101486-pip01-24Avalotcagene Ontaparvovec
  59. mhra-101488-pip01-24etavopivat
  60. mhra-101489-pip01-24Enlicitide (decanoate)
  61. UPADACITINIB
  62. mhra-101492-pip01-24Recombinant Influenza Hemagglutinin-strain A (H1N1 subtype)
  63. mhra-101493-pip01-24anti-alpha-synuclein recombinant humanised monoclonal antibody (Company code UCB7853)
  64. LUSPATERCEPT
  65. mhra-101495-pip01-24Split influenza virus, inactivated containing antigens equivalent to the A/H1N1-like…
  66. mhra-101496-pip01-24zirconium (89Zr) girentuximab senvedoxam
  67. mhra-101497-pip01-24laruparetigene zovaparvovec
  68. mhra-101499-pip01-24Zanidatamab
  69. mhra-101500-pip01-24Zanidatamab
  70. mhra-101506-pip01-24Zongertinib
  71. mhra-101509-pip01-24Ferric Citrate Coordination Complex
  72. ERTUGLIFLOZIN L-PYROGLUTAMIC ACID
  73. FLUTICASONE FUROATE
  74. ECULIZUMAB
  75. mhra-101521-pip01-24Derivative of 6-(piperidine-1-carbonyl)pyridine-3-ol
  76. mhra-101523-pip01-24Raludotatug deruxtecan
  77. mhra-101525-pip01-24Actinium-225-2-(4,7,10-tris-carboxymethyl-1,4,7,10 tetraaza-cyclododec-1-yl)-pentanedioic…
  78. mhra-101538-pip01-24NIVOLUMAB
  79. mhra-101540-pip01-24derivative of pyrindin-2-yl)cyclopropanecarboxamide hydrochloride
  80. mhra-101542-pip01-24lutikizumab
  81. SELUMETINIB HYDROGEN SULFATE
  82. mhra-101546-pip01-24SECUKINUMAB
  83. mhra-101547-pip01-24IgG-like T cell engager binding to DLL3 and CD3
  84. mhra-101548-pip01-24Xaluritamig
  85. mhra-101564-pip01-24(5aSa,17aRa)-20-Chloro-2-[(2S,5R)-2,5-dimethyl-4-(prop-2-enoyl)piperazin-1-yl]-14,17-diflu…
  86. mhra-101570-pip01-24firmonertinib
  87. mhra-101572-pip01-24Nogapendekin alfa
  88. mhra-101573-pip01-24Trofinetide
  89. mhra-101581-pip01-24rinatabart sesutecan
  90. Recombinant Varicella Zoster Virus Glycoprotein E
  91. mhra-101586-pip01-24Ifinatamab deruxtecan
  92. CEFIDEROCOL SULFATE TOSYLATE
  93. mhra-101588-pip01-24Derivative of 1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
  94. mhra-101591-pip01-24SACITUZUMAB GOVITECAN
  95. mhra-101595-pip01-24efinopegdutide
  96. Ibrexafungerp
  97. mhra-101602-pip01-24navepegritide
  98. mhra-101605-pip01-24Telisotuzumab adizutecan
  99. ADRENALINE
  100. mhra-101619-pip01-24spesolimab
  101. mhra-101622-pip01-24Derivative of azabicycloheptane-carboxamide
  102. LISOCABTAGENE MARALEUCEL
  103. IXEKIZUMAB
  104. mhra-101654-pip01-24Volrustomig
  105. mhra-101663-pip01-24AMIVANTAMAB
  106. mhra-101664-pip01-24SECUKINUMAB
  107. mhra-101677-pip01-24Rilvegostomig
  108. mhra-101680-pip01-24CICLOSPORIN
  109. MEPOLIZUMAB
  110. mhra-101690-pip01-24EMPAGLIFLOZIN
  111. ATOGEPANT MONOHYDRATE
  112. mhra-101694-pip01-24Human IgG1 monoclonal antibody targeting amyloid transthyretin
  113. mhra-101702-pip01-24Modified messenger ribonucleic acid encoding individual patient-specific tumour…
  114. IPTACOPAN HYDROCHLORIDE MONOHYDRATE
  115. USTEKINUMAB
  116. mhra-101725-pip01-24GUSELKUMAB
  117. mhra-101737-pip01-24GOZETOTIDE
  118. mhra-101746-pip01-24H-(D)p-Benzoylphenylalanyl-(D)seryl-(D)tryptophanyl-(D)seryl-(D)pentafluorophenylalanyl-(D…
  119. TOFACITINIB CITRATE
  120. Tabelecleucel

About this dataset

A paediatric investigation plan sets out the studies a company must run in children to support authorisation of a medicine in the UK, or records a waiver or deferral.

Source: UK Medicines and Healthcare products Regulatory Agency (MHRA). Contains public sector information licensed under the Open Government Licence v3.0